PRRT2 and diabetic kidney disease: Several studies have reported a direct antioxidative effect of PPARα activation as well [18,19], and Maki et al. witnessed that PEM decreased OS by inhibiting the DAG-PKC pathway in diabetic nephropathy model mice [32].